Polymorphism | Background Prevalence (all D0 samples) N = 48 | Reinfection (D0) N = 2 | Reinfection (DF) N = 2 | |||
---|---|---|---|---|---|---|
 | N | Percent (%) | n | Percent (%) | n | Percent (%) |
Pfk13 | ||||||
 Samples sequenced | 48 | 100 | 2 | 100 | 2 | 100 |
 Wild type (no mutations detected) | 48 | 100 | 2 | 100 | 2 | 100 |
Pfmdr1†| ||||||
 N86 | 47 | 98 | 2 | 100 | 2 | 100 |
 86Y | 1 | 2 | 0 | 0 | 0 | 0 |
 Y184 | 11 | 23 | 0 | 0 | 0 | 0 |
 184Y/F | 2 | 4 | 0 | 0 | 0 | 0 |
 184F | 35 | 73 | 2 | 100 | 2 | 100 |
 S1034 | 48 | 100 | 2 | 100 | 2 | 100 |
 1034C | 0 | 0 | 0 | 0 | 0 | 0 |
 D1246 | 48 | 100 | 2 | 100 | 2 | 100 |
 1246Y | 0 | 0 | 0 | 0 | 0 | 0 |
Samples sequenced for haplotype analysis | ||||||
 NYD | 13 | 27 | 0 | 0 | 0 | 0 |
 YFD | 1 | 2 | 0 | 0 | 0 | 0 |
 NFD | 36 | 75 | 2 | 100 | 2 | 100 |
 NFY | 0 | 0 | 0 | 0 | 0 | 0 |
 NYY | 0 | 0 | 0 | 0 | 0 | 0 |
 YYD | 0 | 0 | 0 | 0 | 0 | 0 |
 YFY | 0 | 0 | 0 | 0 | 0 | 0 |
 YYY | 0 | 0 | 0 | 0 | 0 | 0 |